Search Results - "Pondorfer, P."

C‐reactive protein is an independent prognostic marker in patients with tongue carcinoma ‐ A retrospective study by Graupp, M., Schaffer, K., Wolf, A., Vasicek, S., Weiland, T., Pondorfer, P., Holzmeister, C., Moser, U., Thurnher, D.

“…Objectives Reliable prognostic markers are lacking for tongue carcinoma. C‐reactive protein (CRP) and a ratio from neutrophils/lymphocytes (NLR) are…”
Get full text

Response to C‐reactive protein as an individual prognostic marker in oral cancer: practical considerations by Graupp, M., Schaffer, K., Wolf, A., Vasicek, S., Weiland, T., Pondorfer, P., Holzmeister, C., Moser, U., Thurnher, D.

Get full text

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy by Mollnar, S., Pondorfer, P., Kasparek, A.-K., Reinisch, S., Moik, F., Stotz, M., Halm, M., Szkandera, J., Terbuch, A., Eisner, F., Gerger, A., Kapp, K. S., Partl, R., Vasicek, S., Weiland, T., Pichler, M., Stöger, H., Thurnher, D., Posch, F.

“…Purpose Radiochemotherapy (RCT) is an effective standard therapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Nonetheless, toxicity…”
Get full text